FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro
WEDNESDAY, Nov. 8, 2023 -- A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active...